Rate of Conversion from Prodromal Alzheimer's Disease to Alzheimer's Dementia: A Systematic Review of the Literature
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Background: The purpose of this study was to summarize published estimates for conversion from mild cognitive impairment or amnestic mild cognitive impairment to Alzheimer's dementia. We carried out a systematic review of English language publications to identify cohort studies published since January 2006 that reported the risk or rate of conversion. Summary: Thirty-two cohort studies were identified, of which 14 reported annualized conversion rates (ACRs). Conversions over 1 year ranged from 10.2 to 33.6% (5 studies, median: 19.0%), and over 2 years from 9.8 to 36.3% (7 studies, median: 18.6%). ACRs ranged from 7.5 to 16.5% (7 studies, median: 11.0%) per person-year for studies recruiting from clinics, and from 5.4 to 11.5% (7 studies, median: 7.1%) for community samples. Key Message: Extensive variation was observed in conversion rates due to the population sampled, diagnostic criteria, and duration, and because many studies did not account for loss to follow-up.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“About one-third develop dementia due to Alzheimer's within five years.52”
From 2023 Alzheimer's disease facts and figures (2023) · cites this paper as [52]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“About one‐third develop dementia due to Alzheimer's within five years.”
From 2024 Alzheimer's disease facts and figures (2024) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Mild Cognitive Impairment: Clinical Characterization and Outcome
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L. ‐., Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., et al. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01380.x · Cited by 4,946
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Forecasting the global burden of Alzheimer's disease
Brookmeyer, R., Johnson, E., Ziegler‐Graham, K., & Arrighi, H. M. (2007) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2007.04.381 · Cited by 3,370
Self-citation
Cited by
Items 201–300 of 427
Brain aging and Alzheimer’s disease, a perspective from non-human primates
Ferrer, I. (2024) · Aging · doi:10.18632/aging.206143 · Cited by 17
Sleep trajectories across three cognitive‐aging pathways in community older adults
Zaheed, A. B., Tapia, A. L., Oryshkewych, N., Wheeler, B. J., Butters, M. A., Buysse, D. J., Leng, Y., Barnes, L. L., Lim, A. S. P., Yu, L., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70159 · Cited by 12
“While individuals with MCI are3to5timesmorelikelytoprogresstodementiawithin5years, 25,26 etiologies other than neurodegenerative diseases may contribute to MCI, such as vascular disorders, 27 resulting in a stable lower level of cognitive functioning or returns to normal cognition over time.”
Suh, H.-W., Kim, J., Kwon, O., Cho, S., Kim, J. W., Kwak, H.-Y., Kim, Y., Lee, K. M., Chung, S.-Y., & Lee, J. (2019) · Trials · doi:10.1186/s13063-019-3446-9 · Cited by 10
Marcotte, C., Potvin, O., Collins, D. L., Rheault, S., & Duchesne, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-49914-3 · Cited by 12
Wang, X.-B., Ding, D., Zhao, Q.-H., Liang, X.-N., Peng, L., Zhao, X., Xi, Q., Min, Z., Wang, W., Xu, X.-W., et al. (2020) · Aging · doi:10.18632/aging.102888 · Cited by 8
“5– 23% of MCI patients deteriorate to AD annually [2, 3].”
BackgroundAortic Valve Calcification Is Associated with Future Cognitive Impairment
Chung, H. E., Chen, J. W., Ghosalkar, D. S., Christensen, J. L., Chu, A., Mantsounga, C., Neverson, J., Soares, C., Shah, N. R., Wu, W., et al. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200253 · Cited by 11
Suh, E. H., Lee, G., Jung, S., Wen, Z., Bao, J., Nho, K. T., Huang, H., Davatzikos, C. A., Saykin, A. J., Thompson, P. M., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1281748 · Cited by 9
Development and Initial Validation of the Functional External Memory Aid Tool
Lanzi, A. M., Bourgeois, M. S., & Dedrick, R. F. (2020) · American Journal of Speech-Language Pathology · doi:10.1044/2019_ajslp-19-00075 · Cited by 10
Evaluation of PROMIS Cognitive Function Scores and Correlates in a Clinical Sample of Older Adults
Edelen, M. O., Harrison, J. M., Rodriguez, A., Weir, R. L., Lai, J., Langer, M. M., & Hanmer, J. (2022) · Gerontology and Geriatric Medicine · doi:10.1177/23337214221119057 · Cited by 9
“A systematic review found that approximately one-third of individuals with MCI develop Alzheimer’s dementia within 5 years (Ward et al., 2013).”
BackgroundRamos‐Vera, C., Saintila, J., O'Diana, A. A. G., & Calizaya-Milla, Y. E. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.981944 · Cited by 9
Polden, M., & Crawford, T. J. (2021) · Cortex · doi:10.1016/j.cortex.2021.05.016 · Cited by 11
“The key aspect of this finding is linked to the fact that people with Amnesic MCI are at an increased risk of progressing to develop dementia in the future (Yaffe et al, 2006, Fischer et al, 2007, Ward et al, 2013).”
BackgroundLuna, A. D., & Marcia, R. F. (2021) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc46164.2021.9630598 · Cited by 12
“Another study found that 32% of individuals with MCI developed Alzheimer’s dementia within five years’ follow-up [4].”
BackgroundAlzheimer’s disease classification from hippocampal atrophy based on PCANet-BLS
Liang, C., Lao, H., Wei, T., & Zhang, X. (2022) · Multimedia Tools and Applications · doi:10.1007/s11042-022-12228-0 · Cited by 9
“Alex’s review [30] shows that about 32% of MCI patients will develop into AD within 5 years, while the conversion rate of the normal elderly is only about 1%.”
Li, Y., Wang, K., Shi, G., Qi, A., Li, Y., Jiao, Y., Hu, R., Hu, G., Li, Y., Shen, Z., et al. (2025) · Environmental Research · doi:10.1016/j.envres.2025.121726 · Cited by 11
O espectro clínico e laboratorial da doença de Alzheimer: Uma perspectiva neurológica
Moreira, M. A., & Moreira, S. V. (2020) · Revista Psicologia em Pesquisa · doi:10.34019/1982-1247.2020.v14.30649 · Cited by 20
Fernandes, C., Macedo, I., Barbosa, F., & Teixeira, J. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.10.030 · Cited by 9
Andrés‐Benito, P., Íñigo-Marco, I., Brullas, M., Carmona, M., del Río, J. A., Fernández‐Irigoyen, J., Santamaría, E., Povedano, M., & Ferrer, I. (2023) · Aging · doi:10.18632/aging.204698 · Cited by 9
Kasani, P. H., Kassani, S. H., Kim, Y., Yun, C., Choi, S. H., & Jang, J. (2021) · International Conference on Information and Communication Technology Convergence (ICTC) · doi:10.1109/ictc52510.2021.9620780 · Cited by 11
Zhu, J., Shi, R., Su, C., Dai, L., Tian, S., Feng, Y., Gu, P., Shariff, M., Nguyen, T., Ye, Y., et al. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/7898093 · Cited by 8
Kokje, E., Çelik, S., Wahl, H., & von Stutterheim, C. (2021) · European Journal of Ageing · doi:10.1007/s10433-021-00619-5 · Cited by 9
Ávila‐Villanueva, M., & Ávila, J. (2024) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2024.00090 · Cited by 9
Alzheimer’s Disease and Other Dementias
Brugulat‐Serrat, A., Shaaban, C. E., Emrani, S., & Sundermann, E. E. (2025) · Springer eBooks · doi:10.1007/978-3-031-87228-0_5 · Cited by 7
Khotbehsara, M. M., Soar, J., Lokuge, S., Khotbehsara, E. M., & Ip, W. K. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14155475 · Cited by 11
“MCI impacts about 15 to 20 percent of individuals over 65, with 10 to 15 percent progressing to dementia each year [1,2].”
Wang, H., Yu, H., Song, K., Xiong, F., & Zhang, H. (2020) · Medicine · doi:10.1097/md.0000000000022187 · Cited by 8
Cheng, J., Ji, X., He, L., Zhang, Y., TongTong, X. I. A. O., Geng, Q., Wang, Z., Qi, S., Zhou, F., & Zhan, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010028 · Cited by 9
“Many studies have shown that the gradual loss of oligodendrocytes and myelin [11,12] is also a key factor leading to a decline in cognitive ability and pathological state repair ability.”
BackgroundGopalakrishna, G., Brunton, S., Pruzin, J. J., Alford, S., Hamersky, C. M., & Sabharwal, A. K. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05129-5 · Cited by 8
“Patients with MCI due to AD have underlying AD pathology and will progress to mild AD dementia, many within two years [7].”
BackgroundJang, H., Na, D. L., Kwon, J. C., Jung, N., Moon, Y., Lee, J. S., Park, K.-W., Lee, A. Y., Cho, H., Lee, J., et al. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230189 · Cited by 7
Rigby, T., Gregoire, A., Reader, J., Kahsay, Y., Fisher, J., Kairys, A. E., Bhaumik, A., Rahman‐Filipiak, A., Maher, A. C., Hampstead, B. M., et al. (2024) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617724000213 · Cited by 7
Suh, H.-W., Seol, J.-H., Bae, E.-J., Kwak, H.-Y., Hong, S., Park, Y.-S., Lim, J. H., & Chung, S.-Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/8820705 · Cited by 8
“,e long-term effect is especially important in MCI because MCI has a risk of conversion to dementia (particularly AD), and AD is a degenerative and progressive disorder [2].”
RetractedPrognosis of amnestic mild cognitive impairment: clinical and immunological correlations
Пономарева, Е. В., Krinsky, S. A., & Si, G. (2021) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202112110216 · Cited by 7
Bohlken, J., & Kostev, K. (2016) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-0042-119863 · Cited by 7
Alzheimer's Disease — Perspective from Political Science: Public Policy Issues
Blank, R. H. (2018) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110518804234 · Cited by 8
Temporal dynamics of animacy categorization in the brain of patients with mild cognitive impairment
Karimi, H., Marefat, H., Khanbagi, M., Kalafatis, C., Modarres, M. H., Vahabi, Z., & Khaligh‐Razavi, S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264058 · Cited by 8
“A systematic review of 32 cohort studies shows an average of 32 percent conversion from MCI to Alzheimer's Disease (AD) within a five-year follow-up (Ward et al. 2013).”
Diurnal cortisol, neuroinflammation, and neuroimaging visual rating scales in memory clinic patients
Holleman, J., Daniilidou, M., Kåreholt, I., Aspö, M., Hagman, G., Udeh‐Momoh, C. T., Spulber, G., Kivipelto, M., Solomon, A., Matton, A., et al. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.03.024 · Cited by 6
Juday, T. R., Holub, A. A., Mattke, S., Betts, K. A., Kitchen, S. A., Liu, H., Batrla, R., Frech, F. H., & Khachaturian, A. S. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241297128 · Cited by 6
Rigby, T., Kavcic, V., Shair, S. R., Hill‐Jarrett, T. G., García, S., Reader, J., Persad, C. C., Bhaumik, A., Pal, S., Hampstead, B. M., et al. (2024) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617724000444 · Cited by 7
Zhang, L., Tian, J., Liu, X., Wang, L., & Yang, L. (2025) · Geriatric Nursing · doi:10.1016/j.gerinurse.2025.103530 · Cited by 7
Marra, A., Naro, A., Chillura, A., Bramanti, A., Maresca, G., Luca, R. D., Manuli, A., Bramanti, P., & Calabrò, R. S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170973 · Cited by 6
Chen, M. Z., Chan, Y. H., Wong, M. W. K., & Merchant, R. A. (2022) · Psychogeriatrics · doi:10.1111/psyg.12841 · Cited by 8
Polden, M., & Crawford, T. J. (2023) · Vision · doi:10.3390/vision7020038 · Cited by 8
“People with aMCI are deemed at a greater risk of progressing to AD then naMCI [25,26].”
BackgroundGorecka, M. M., Vasylenko, O., Waterloo, K. K., & Rodríguez‐Aranda, C. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.718900 · Cited by 6
de Oliveira, M. P. B., Moreira, R. D. F. C., Serrão, P. R. M. D. S., dos Santos, J. G., da Silva, D. C. P., & de Andrade, L. P. (2022) · Disability and Rehabilitation · doi:10.1080/09638288.2022.2040609 · Cited by 8
Lu, J. W., Zeng, W., Zhang, L., & Shi, Y. (2022) · Concepts in Magnetic Resonance Part B · doi:10.1155/2022/1047616 · Cited by 6
“[4] showed that about 32% of MCI patients would develop AD within 5 years, while the annual conversion rate of the elderly with normal cognitive function was only about 1%.”
BackgroundMulti-Features Fusion in Multi-plane MRI Images for Alzheimer’s Disease Classification
(2022) · International journal of intelligent engineering and systems · doi:10.22266/ijies2022.0831.17 · Cited by 9
Wit, L. D., Levy, S.-A. T., Kurasz, A. M., Amofa, P., DeFeis, B. L., O’Shea, D. M., Chandler, M. J., & Smith, G. E. (2022) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2022.2089697 · Cited by 7
“…(AD) or other © 2022 Informa UK Limited, trading as Taylor & Francis Group CONTACT Glenn E. Smith glennsmith@phhp.ufl.edu Department of Clinical and Health Psychology, University of Florida, Gainesville 32611-7011, FL, USA neurodegenerative conditions (Petersen et al., 2018; Ward et al., 2013).”
BackgroundKim, Y., Kim, S., & Yang, H. (2023) · Geriatric Nursing · doi:10.1016/j.gerinurse.2023.07.002 · Cited by 5
Perron, J., Scramstad, C., & Ko, J. H. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230633 · Cited by 7
Virtual cognitive training in healthy aging and mild cognitive impairment
Basak, C., & Qin, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811272-4.00009-9 · Cited by 8
New Horizons in Early Dementia Diagnosis: Can Cerebellar Stimulation Untangle the Knot?
Naro, A., Marra, A., Billeri, L., Portaro, S., Luca, R. D., Maresca, G., Rosa, G. L., Lauria, P., Bramanti, P., & Calabrò, R. S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091470 · Cited by 7
“Some EEG features (including EEG power density, functional coupling, and spectral coherence) have been tested for their usefulness in differentiating dementia and MCI at the prodromal stage [4,5].”
BackgroundLi, Y., Fang, Y., Wang, J., Zhang, H., & Hu, B. (2021) · BioMed Research International · doi:10.1155/2021/5531940 · Cited by 7
“On average, 32 percent of individuals with MCI will convert to AD within 5 years [4].”
BackgroundLi, Y., Fang, Y., Zhang, H., & Hu, B. (2019) · IEEE Access · doi:10.1109/access.2019.2936415 · Cited by 6
Impairment for Medication Management in Older Adults: Validity of a Family Report Measure
Schmidt, N. E., Steffen, A., & Meuser, T. M. (2020) · Clinical Gerontologist · doi:10.1080/07317115.2019.1703064 · Cited by 6
Staging cognitive impairment and incidence of dementia
Santabárbara, J., López‐Antón, R., Gracia‐García, P., De‐la‐Cámara, C., Vaquero-Puyuelo, D., Lobo, E., Marcos, G., Salvador‐Carulla, L., Palomo, T., Sartorius, N., et al. (2015) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015000918 · Cited by 7
“A considerable number of studies, including studies conducted in the community have reported the association of cognitive impairment and dementia, including Alzheimer’s disease (Ward et al. 2013), particularly in the field of the so called ‘mild cognitive impairment’ (Mitchell & Shiri-Feshki, 2009).”
BackgroundKushari, S., Saha, D., Kalita, J. M., Kalita, T., Kalita, P., Chakraborty, J., Kumar, S., Das, T., & Patowary, L. (2025) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2025.100020 · Cited by 6
Baik, K., Kang, M., Park, Y. J., Chung, S. J., Oh, K., Koh, S., & Kang, S. H. (2025) · Scientific Reports · doi:10.1038/s41598-025-16620-2 · Cited by 7
Perron, J., & Ko, J. H. (2022) · Applied Sciences · doi:10.3390/app122211463 · Cited by 6
Advancing Cognitive Health in Aging Populations by Leveraging Digital Assessment
Coppola, Q., Yangüez, M., Tullo, D., Jaeggi, S. M., & Seitz, A. R. (2024) · Journal of Health Service Psychology · doi:10.1007/s42843-024-00102-6 · Cited by 5
“Despite the pressing need of patients and clinicians for reliable and valid low-cost assessment tools that enable early detection of abnormal cognitive decline, most clinicians still rely on traditional single-time point paper-pencil screening measures, which not only show weak associations with ADRD biomarkers (Duke…”
InfluentialPhasic alerting increases visual processing speed in amnestic mild cognitive impairment
Haupt, M., Joedecke, S., Srowig, A., Napiórkowski, N., Preul, C., Witte, O. W., & Finke, K. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.031 · Cited by 6
Impaired Recognition of Facial and Vocal Emotions in Mild Cognitive Impairment
Moreira, H. S., Costa, A. S., Machado, Á. S., Castro, S. L., Vicente, S., & Lima, C. F. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 5
Chang, Z., Wang, Y.-C., Tian, D., Hu, W., Wang, Z., Liu, G., Ma, H.-P., Hu, Y., Wu, B., & Han, Z. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/2478940 · Cited by 8
Abulafia, C., Vidal, M. F., Olivar, N., Odzak, A. N., Brusco, I., Guinjoan, S. M., Cardinali, D. P., & Vigo, D. E. (2023) · Clinical Interventions in Aging · doi:10.2147/cia.s394749 · Cited by 6
“MCI is present in 15–25% of older adults over 65 years old and 32% of MCI subjects convert to dementia due to Alzheimer’s disease (AD) (the main cause for dementia) over a fiveyear period.(2) For this reason, MCI is a critical stage to assess subjects at risk of developing dementia and a promising target population to…”
BackgroundA joint autoencoder and classifier deep neural network for AD and MCI classification
Ganotra, R., Gupta, S., & Dora, S. (2024) · International Journal of Imaging Systems and Technology · doi:10.1002/ima.23054 · Cited by 6
“6 – 8 However, in many cases, MCI patients stay stable for several years or advance towards a form of dementia other than AD.”
BackgroundAmyloid-β Pathology Is the Common Nominator Proteinopathy of the Primate Brain Aging
Ferrer, I. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240389 · Cited by 7
Rural‐Urban mild cognitive impairment comparison in West Michigan through EHR
Zhang, X. C., Witteveen‐Lane, M., Skovira, C. M., Dave, A. A., Jones, J. S., McNeely, E., Lawrence, M. R., Morgan, D., Chesla, D. W., & Chen, B. (2024) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12495 · Cited by 9
Wolf, L. K., & Gunderman, R. B. (2019) · American Journal of Roentgenology · doi:10.2214/ajr.19.21506 · Cited by 8
Protective Factors Modulate the Risk of Beta Amyloid in Alzheimer’s Disease
Zhou, B., Tanabe, K., Kojima, S., Teramukai, S., Fukushima, M., & Initiative, T. A. D. N. (2020) · Behavioural Neurology · doi:10.1155/2020/7029642 · Cited by 6
Yuan, M., Lian, S., Li, X., Long, X., Fang, Y., & Initiative, A. D. N. (2024) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.6079 · Cited by 7
“22,23 Therefore, in this study we calculated the time ‐ dependent AUC and Brier Score at the follow ‐ up times of 1,2,3 years(T) for both the 2 ‐ year and 5 ‐ year prediction spans ( Δ t ).”
MethodUnsupervised Pre-training of the Brain Connectivity Dynamic Using Residual D-Net
Seo, Y., Morante, M., Kopsinis, Y., & Theodoridis, S. (2019) · Lecture notes in computer science · doi:10.1007/978-3-030-36718-3_51 · Cited by 5
Bartl, G., Blackshaw, E., Crossman, M., Allen, P., & Sandrini, M. (2020) · Zeitschrift für Psychologie · doi:10.1027/2151-2604/a000396 · Cited by 5
Park, M., Ahn, J., Lim, J., Hwang, S., & Kim, K. (2025) · GeroScience · doi:10.1007/s11357-025-01869-2 · Cited by 4
“MCI is characterized by objective cognitive impairment that does not substantially interfere with an individual’s daily life activities [4]; however, the risk of progression to AD dementia increases over time [5–7].”
Association between periodontal disease and Alzheimer's disease: a scoping review
Zhang, X., Huang, X., & Chang, M. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1588008 · Cited by 8
Wei, M., Li, Y., Liang, M., Xi, M., & Tian, H. (2023) · Academic Journal of Science and Technology · doi:10.54097/ajst.v5i3.8015 · Cited by 4
“Studies have shown that 32% of MCI patients will develop AD within five years, while the annual conversion rate of AD among cognitively normal elderly is only about 1% [5].”
BackgroundMild cognitive impairment: what's next?
Tabeeva, G. R. (2019) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2019119101103 · Cited by 4
Bhasin, H., & Agrawal, R. K. (2021) · IEEE International Conference on Bioinformatics and Bioengineering (BIBE) · doi:10.1109/bibe52308.2021.9635485 · Cited by 4
“The annual conversion rate of MCI to dementia is around 15-20% [2].”
BackgroundBhasin, H., Agrawal, R. K., & Initiative, A. D. N. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12565 · Cited by 4
Serum cystatin C and mild cognitive impairment: The mediating role of glucose homeostasis
Li, K., Xu, J., Zhao, M., Wu, J., Mei, Y., Zhou, Q., Zhao, J., Li, Y., Yang, M., & Xu, Q. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1102762 · Cited by 4
“Mild cognitive impairment (MCI) represents the prodromal stage of dementia, with a progression rate of 20 to 60% within 2–4 years (Ward et al., 2013).”
BackgroundGómez-Gómez, C., Moya-Molina, M. Á., Tey-Aguilera, M. J., Flores-Azofra, J., & González-Caballero, J. L. (2023) · Healthcare · doi:10.3390/healthcare11152219 · Cited by 5
Dyer, A. H., Dolphin, H., O’Connor, A., Morrison, L., Sedgwick, G., McFeely, A., Killeen, E., Gallagher, C., Davey, N., Connolly, E., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-077772 · Cited by 5
“21 One of the greatest challenges at present is predicting the variable disease trajectory in those affected by MCI, and there is an urgent need for new clinical, diagnostic and biological markers that may indicate a greater likelihood of disease progression.”
BackgroundBrain metabolic imaging-based model identifies cognitive stability in prodromal Alzheimer’s disease
Perron, J., Scramstad, C., & Ko, J. H. (2025) · Scientific Reports · doi:10.1038/s41598-025-02039-2 · Cited by 5
Jamka, M., Makarewicz-Bukowska, A., Wasiewicz-Gajdzis, M., Brylak, J., Wielińska-Wiśniewska, H., Pawlak, Z., Nowak, J. K., Herzig, K., Mądry, E., & Walkowiak, J. (2021) · Journal of Medical Science · doi:10.20883/medical.e530 · Cited by 4
Prediction of Cognitive Decline for Enrichment of Alzheimer's Disease Clinical Trials
Tam, A., Laurent, C., Gauthier, S. G., & Dansereau, C. L. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.49 · Cited by 32
“3% of MCI patients progress to AD dementia within two years of followup (42).”
BackgroundValentine, K. D., Vo, H., Mancini, B., Urman, R. D., Arias, F., Barry, M. J., & Sepucha, K. (2023) · Medical Decision Making · doi:10.1177/0272989x231182436 · Cited by 6
Hu, Y., Seo, D., Huber, L. L., Shih, P. C., & Lin, H. (2024) · Journal of Applied Gerontology · doi:10.1177/07334648241237340 · Cited by 4
“Given that an average of 32 – 38% of MCI patients developed dementia within 5 years (Mitchell & Shiri-Feshki, 2009; Ward et al., 2013), investigating the association between chronic pain and clinically-de fi ned MCI provides evidence for pain management interventions in the early stage.”
Li, Q., Lv, X., Qian, Q., Liao, K., Du, X., & Initiative, A. D. N. (2024) · Human Brain Mapping · doi:10.1002/hbm.26709 · Cited by 3
“Multiple demographic (Mitchell & Shiri-Feshki, 2009; Ward et al., 2013), clinical (Agostini et al., 2016; Tarawneh & Holtzman, 2012), psychological (Mazzeo et al., 2016; Perri et al., 2007), and neuroimaging biomarkers (Spalletta et al., 2014; Yuan et al., 2009) have been considered as potential…”
BackgroundRegional Abnormality Representation Learning in Structural MRI for AD/MCI Diagnosis
Choi, J.-S., Lee, E., & Suk, H. (2018) · Lecture notes in computer science · doi:10.1007/978-3-030-00919-9_8 · Cited by 4
A Study on PHF-Tau Network Effected by Apolipoprotein E4
Li, Y., Yao, Z., Yang, Y., Zhao, F., Fu, Y., Zou, Y., Hu, B., & Initiative, A. D. N. (2020) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317520971414 · Cited by 4
“Because the progression from MCI to AD is crucial, more and more studies have concentrated on MCI.”
InfluentialShao, W., He, X., Li, X., Tao, W., Zhang, J., Zhang, S., Wang, L., Qiao, Y., Wang, Y., Zhang, Z., et al. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210324115817 · Cited by 5
Puttaert, D., Coquelet, N., Wens, V., Peigneux, P., Fery, P., Rovaï, A., Trotta, N., Bier, J. C., Goldman, S., & Tiège, X. D. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.18.101683 · Cited by 4
Chen, J. J., Thiyagarajah, M. T., Song, J., Chen, C. C., Herrmann, N., Gallagher, D., Rapoport, M. J., Black, S. E., Ramirez, J., Andreazza, A. C., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-430047/v1 · Cited by 4
Chu, C., Lin, Y., Tsai, C.-L., Sung, Y., Tsai, C., Lin, G., Ko, C.-A., Liu, Y., Liang, C., & Yang, F. (2025) · Psychiatry Investigation · doi:10.30773/pi.2024.0094 · Cited by 5
Yan, J. T., Dillon, A., Meng, T., Ramesh, V., Sabbagh, M. N., Sharma, V., & Roth, S. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70156 · Cited by 4
Guo, Z., Jiang, Y., He, J., & Jiang, N. (2025) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70707 · Cited by 6
“Approximately 15% MCI patients progress to dementia within 2 years [3], with about 1/3 developing dementia due to AD within 5 years [4].”
Brembati, V., Crescenti, D., Geviti, A., Rossini, E., Cazzaniga, F. A., Moda, F., Zanier, E. R., Guerrera, G., Battistini, L., Baiardi, S., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01897-2 · Cited by 6
“Compared to cognitively normal subjects, patients with MCI have a higher risk of conversion to dementia [15–17], but only 30–40% of them progress to dementia if followed-up for 3 to 5 years, while the remaining never become demented or even reverse to normal from the MCI stage [11, 18, 19].”
Moon, J. P., Jabbar, K. B. A., Tay, T. C. I., Tay, L., Mahendran, R., Ng, T. P., Tan, S. M., Koh, W. Z. H., Ying, W.-Y., Tan, A., et al. (2026) · JMIR Research Protocols · doi:10.2196/79490 · Cited by 3
“MCI affects 6% ‐ 20% of people aged 60 ‐ 89 years [8-10], and it is recognized as a prodromal stage of dementia, with a high probability of progression to dementia within 1 to 3 years [11,12].”
The Mediating Role of Inflammation in the Relationship Between α-Synuclein and Cognitive Functioning
Dabiri, S., Ramirez-Ruiz, M., Jean‐Louis, G., Ntekim, O. E., Obisesan, T. O., Campbell, A. L., Mwendwa, D. T., & Initiative, A. D. N. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac217 · Cited by 3
Tague, D. B., & Lipe, A. W. (2023) · Nordic Journal of Music Therapy · doi:10.1080/08098131.2023.2197985 · Cited by 3
“Because the risk of developing dementia among people with MCI is particularly high (Ward et al., 2013”
BackgroundBurns, R. B., Barry, M. J., Blacker, D., & Kanjee, Z. (2023) · Annals of Internal Medicine · doi:10.7326/m23-1808 · Cited by 5
“Although some persons with MCI will progress to dementia — about a third over 5 years and about half over 10 years (3) — about 40% may return to normal cognitive functioning over 2 to 3 years (4).”
BackgroundMitigating cognitive impairment in aging mice: Exploring the therapeutic potential of ischelium
Chen, Y., Cheng, W., Tang, J., Xiao, B., Kuang, M., Xu, L., & Liu, H. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149173 · Cited by 3
Shi, J., Zhang, M., Hu, Y., Liu, J., Li, K., Sun, X., Chen, S., Liu, J., Ye, L., Fan, J., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106909 · Cited by 4
“Furthermore, mild cognitive impairment (MCI), considered an intermediate state between normal cognition and dementia, affects approximately 16 – 20 % of older adults (Roberts and Knopman, 2013), with over 30 % MCI cases progressing to dementia within 5 years or more (Ward et al., 2013).”
Liu, D., Tian, Y., Liu, M., & Yang, S. (2025) · BMC Public Health · doi:10.1186/s12889-025-23310-1 · Cited by 5
“Additionally, the annual conversion rate from MCI to AD is 20%, significantly higher than the 2% conversion rate observed in healthy older adults [5], AD not only severely impacts the quality of life of patients but also imposes a significant economic and caregiving burden on families and society.”
Metadata
- Authors
- Ward, A., Tardiff, S., Dye, C., & Arrighi, H. M.
- Affiliations
- Janssen Alzheimer Immunotherapy Research & Development (United States) (US)
- Corresponding author
- Arrighi, H. Michael
- ORCID
- Ward, Alex
- Venue
- Dementia and Geriatric Cognitive Disorders Extra
- Publisher
- S. Karger AG
- Published
- 2013-09-28
- Volume
- 3
- Issue
- 1
- Pages
- 320-332
- ISSN
- 1664-5464 (ISSN-L)
- PMC
- PMC3808216
- OpenAlex
- W2010643121
- Cited by
- 426
- References
- 68
- Citations by year
- 2026: 28 · 2025: 47 · 2024: 64 · 2023: 61 · 2022: 44 · 2021: 60 · 2020: 32 · 2019: 30 · 2018: 26 · 2017: 5 · 2016: 14 · 2015: 11 · 2014: 4
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/3.0/ (vor)
- creativecommons.org/licenses/by-nc/3.0/ (tdm)
- Locations
- Dementia and Geriatric Cognitive Disorders Extra (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- prodromal Alzheimer's disease, Alzheimer's dementia, conversion rate, mild cognitive impairment, amnestic mild cognitive impairment, cohort studies, loss to follow-up, diagnostic criteria
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
